GL1X · GenesisL1 explorer

Research workbench

EPHB3 kinase domain covalently bound to an irreversible inhibitor (compound 3)

Analyse EPHB3 kinase domain covalently bound to an irreversible inhibitor (compound 3) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5L6O
Type
protein
Length
267 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Ephrin type-B receptor 3
EC
2.7.10.1
UniProt
P54753
Ligands
6P6
Pockets
2 · best druggability 0.67

Structure

x-ray diffraction · 1 distinct chain · 40% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AEphrin type-B receptor 3 (EC 2.7.10.1)protein26740% helix, 16% strandP54753

Ligands and binding sites

  • 6P6 · 1-(4-phenylazanylquinazolin-7-yl)ethanone · ligand · chains A
  • DIO · 1,4-diethylene dioxide · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12000.670.85256P6
22680.500.7445empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 5L6O · EphB3 kinase domain covalently bound to an irreversible inhibitor (compound 3) · the same entry in another collection · chain A against A, TM-score 1.00
  • P54753 · AlphaFold monomer V2.0 prediction for ephrin type-B receptor 3 (P54753) · a predicted model of the same protein · chain A against A, TM-score 0.94

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.